Shkreli: I'll Win Upcoming Fraud Trial by 'Landslide'

Dec.23 -- Former Turing Pharmaceuticals CEO Martin Shkreli discusses the controversy surrounding his raising of pricing for the drug Daraprim and talks about his upcoming securities fraud trial on charges related to hedge funds he ran prior to Turing. He speaks on "Bloomberg Daybreak: Americas."

• #خبری
• #bloomberg